4202 Stock Overview
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Daicel Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,447.50 |
| 52 Week High | JP¥1,539.50 |
| 52 Week Low | JP¥1,055.00 |
| Beta | 0.62 |
| 1 Month Change | -4.74% |
| 3 Month Change | 1.54% |
| 1 Year Change | 35.53% |
| 3 Year Change | 71.30% |
| 5 Year Change | 16.55% |
| Change since IPO | 137.30% |
Recent News & Updates
Daicel's (TSE:4202) Dividend Will Be ¥25.00
Mar 27
Is Daicel (TSE:4202) A Risky Investment?
Mar 23Daicel (TSE:4202) Has Announced A Dividend Of ¥25.00
Mar 05Shareholder Returns
| 4202 | JP Chemicals | JP Market | |
|---|---|---|---|
| 7D | 4.1% | -2.0% | -0.5% |
| 1Y | 35.5% | 27.7% | 28.3% |
Return vs Industry: 4202 exceeded the JP Chemicals industry which returned 27.7% over the past year.
Return vs Market: 4202 exceeded the JP Market which returned 28.3% over the past year.
Price Volatility
| 4202 volatility | |
|---|---|
| 4202 Average Weekly Movement | 4.5% |
| Chemicals Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 4202 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4202's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 11,207 | Yoshimi Ogawa | www.daicel.com |
Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, such as functional films and materials for use in smartphones, PCs, TVs, and in-vehicle displays; polymers and solvents for use in the semiconductor manufacturing process; optical lenses for use in VR, smartphones, and various sensors; printed electronic materials; and organic semiconductors.
Daicel Corporation Fundamentals Summary
| 4202 fundamental statistics | |
|---|---|
| Market cap | JP¥399.25b |
| Earnings (TTM) | JP¥55.34b |
| Revenue (TTM) | JP¥547.79b |
7.2x
P/E Ratio0.7x
P/S RatioIs 4202 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4202 income statement (TTM) | |
|---|---|
| Revenue | JP¥547.79b |
| Cost of Revenue | JP¥396.75b |
| Gross Profit | JP¥151.04b |
| Other Expenses | JP¥95.69b |
| Earnings | JP¥55.34b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | 200.65 |
| Gross Margin | 27.57% |
| Net Profit Margin | 10.10% |
| Debt/Equity Ratio | 92.9% |
How did 4202 perform over the long term?
See historical performance and comparison